News Focus
News Focus
icon url

biotech_researcher

10/24/11 6:18 PM

#13509 RE: biomaven0 #13508

I personally wouldn't be averse to partnering Europe too if it was with a company that could help aggressively develop other indications.



Totally agree with that, as long as it was with SNY.
icon url

BuyOnDips

10/24/11 9:25 PM

#13510 RE: biomaven0 #13508

Quote: An NDA can be as much as 100,000 pages,
With the USA FDA process this is almost a given. No wonder many Companies’s are going to the EU first and even passing on USA applications altogether? I’m aware of the changes our FDA is currently undergoing, and there is a monetary reason for this? IMHO
icon url

rkrw

10/25/11 10:18 AM

#13518 RE: biomaven0 #13508

I see your point but I would vote against partnering Europe! Follow the Celgene model, retain US+EU.

<< I personally wouldn't be averse to partnering Europe too if it was with a company that could help aggressively develop other indications.>>>